The Flowr Corporation Announces Second Quarter 2020 Earnings Date
19 August 2020 - 6:30AM
The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the
“Company”) announces that the Company will release its second
quarter 2020 results after the close of the financial markets on
Wednesday August 26th, 2020, which will be followed by a conference
call and webcast to review these results on Wednesday August 26th,
at 5:30pm Eastern Time.
Conference call and webcast details are
as follows:
Toll Free: (888) 869-1189 Toll/International:
1-(706) 643-5902Passcode: 8867395Webcast:
flowrcorp.com/investorsOnline registration:
http://www.directeventreg.com/registration/event/8867395
Conference call replay details are as follows:
Toll Free: 1-800-585-8367Toll/International:
1-416-621-4642Passcode: 8867395Webcast: flowrcorp.com/investorsThe
replay of the conference call will be available through midnight on
Wednesday, September 9th, 2020.
About The Flowr Corporation
The Flowr Corporation is a Toronto-headquartered
cannabis company with operations in Canada, Europe, and
Australia. Its Canadian operating campus, located in Kelowna,
BC, includes a purpose-built, GMP-designed indoor cultivation
facility; an outdoor and greenhouse cultivation site; and a
state-of-the-art R&D facility. From this campus, Flowr
produces recreational and medicinal products.
Internationally, Flowr intends to service the global medical
cannabis market through its subsidiary Holigen, which has a license
for cannabis cultivation in Portugal and operates GMP licensed
facilities in both Portugal and Australia.
Flowr aims to support improving outcomes through
responsible cannabis use and, as an established expert in cannabis
cultivation, strives to be the brand of choice for consumers and
patients seeking the highest-quality craftsmanship and product
consistency across a portfolio of differentiated cannabis
products.
For more information, please visit flowrcorp.com
or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr
Corporation.
On behalf of The Flowr Corporation:Vinay
ToliaCEO and Director
CONTACT INFORMATION:
INVESTORS & MEDIA:Thierry ElmalehHead of Capital
Markets(877) 356-9726 ext. 1528thierry@flowr.ca
Forward-Looking Information and Statements
This press release contains “forward-looking
information” within the meaning of Canadian securities laws, which
may include but is not limited to: the release date for the
Company’s second quarter 2020 results, and related conference call
and webcast; Flowr servicing the global medical cannabis market and
operating GMP-designed manufacturing facilities in Portugal and
Australia; Flowr supporting improving outcomes through responsible
cannabis use and striving to be the brand of choice for consumers
and patients seeking highest-quality craftmanship and product
consistency; and Flowr’s business, production and products. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “is expected”, “expects”,
“scheduled”, “intends”, “contemplates”, “anticipates”, “believes”,
“proposes” or variations (including negative and grammatical
variations) of such words and phrases, or state that certain
actions, events or results “may”, “could”, “would”, “might” or
“will” be taken, occur or be achieved. Such information and
statements are based on the current expectations of Flowr’s
management and are based on assumptions and subject to risks and
uncertainties. Although Flowr’s management believes that the
assumptions underlying such information and statements are
reasonable, they may prove to be incorrect. The forward-looking
events and circumstances discussed in this press release may not
occur by certain specified dates or at all and could differ
materially as a result of known and unknown risk factors and
uncertainties affecting Flowr, including risks relating to: Flowr
being unable to release its second quarter 2020 results on the
anticipated date, or at all; Flowr being unable to host the related
conference call and webcast on the anticipated date, or at all;
Flowr being unable to service the global medical cannabis market
and/or operate GMP-designed manufacturing facilities in Portugal
and Australia; Flowr being unable to support improving outcomes
through responsible cannabis use and/or striving to be the brand of
choice for consumers and patients seeking highest-quality
craftmanship and product consistency; the construction and
development of the Company’s cultivation and production facilities;
general economic and stock market conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments in Canada and elsewhere; the cannabis industry in
Canada generally; the ability of Flowr to implement its business
strategies; Flowr’s inability to produce or sell premium quality
cannabis, risks and uncertainties detailed from time to time in
Flowr’s filings with the Canadian Securities Administrators; the
Company’s inability to raise capital or have the liquidity to
operate or advance its strategic initiatives and many other factors
beyond the control of Flowr.
Although Flowr has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking information or statements, there may be other
factors that cause actions, events or results to differ from those
anticipated, estimated or intended. No forward-looking information
or statement can be guaranteed. Except as required by applicable
securities laws, forward-looking information and statements speak
only as of the date on which they are made and Flowr undertakes no
obligation to publicly update or revise any forward-looking
information or statements, whether as a result of new information,
future events or otherwise. When considering such forward-looking
information and statements, readers should keep in mind the risk
factors and other cautionary statements in Flowr’s Annual
Information Form dated April 29, 2020 (the “AIF”) and filed with
the applicable securities regulatory authorities in Canada. The
risk factors and other factors noted in the AIF could cause actual
events or results to differ materially from those described in any
forward-looking information or statements.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Apr 2024 to May 2024
The Flowr (TSXV:FLWR)
Historical Stock Chart
From May 2023 to May 2024